Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 164.20M
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 -0.20M
September 30, 2019 -0.40M
June 30, 2019 -0.30M
March 31, 2019 0.00
December 31, 2018 -0.30M
September 30, 2018 134.00M
June 30, 2018 156.90M
March 31, 2018 108.10M
December 31, 2017 -0.20M
September 30, 2017 133.00M
June 30, 2017 58.00M
March 31, 2017 0.00
December 31, 2016 10.20M
September 30, 2016 -4.70M
June 30, 2016 -0.40M
March 31, 2016 -3.10M
December 31, 2015 501.30M
September 30, 2015 -2.20M
June 30, 2015 -2.90M
March 31, 2015 -1.10M
June 30, 2014 -8.10M
March 31, 2014 -2.00M
December 31, 2013 4.00M
September 30, 2013 3.80M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc --
Jazz Pharmaceuticals Plc -22.70M
GH Research Plc -111.58M
Cosmo NV --
Viatris, Inc. 149.30M